Cardio Diagnostics receives Nasdaq equity deficiency notice; claims cure via Yorkville conversion

Cardio Diagnostics Holdings, Inc.

Nasdaq notified CDIO on Nov 20, 2023 of non-compliance with $2.5M minimum stockholders' equity requirement.
Reported equity of $2,287,731 as of Sep 30, 2023, below the required threshold.
Yorkville fully converted debentures on Oct 31, 2023, raising equity to $4,044,689; company asserts compliance regained.
Nasdaq will monitor; failure in next periodic report could trigger delisting. Company exploring financing options.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.